BeStock  
Markets › Compare › ABCL vs VRDN

ABCL vs VRDN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ABCL · AbCellera Biologics$9.69 ▼ 7.45%
VRDN · Viridian Therapeutics$29.96 ▼ 4.71%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

19124228333438Nov 24, '25May 26, '26Nov 20, '26
  • ABCL +171.4%
  • VRDN -6.5%

Head to head

MetricABCLVRDN
Price$9.69$29.96
Change today▼ 7.45%▼ 4.71%
Market cap$3.16B$3.40B
Return, 3 months-8.7%+24.7%
Return, year to date+183.3%-3.7%
Return, 1 year+176.1%-1.3%
P/E (TTM)––
P/B3.07.0
P/E percentile vs own 5y6th12th
Dividend yield––
Revenue growth (YoY, latest qtr)+18.8%-63.5%
Net profit growth (YoY)+28.6%-192.5%
Gross margin–94.1%
Operating margin-275.7%-1,781.4%
Net margin-218.6%-1,741.9%
Return on equity-14.6%-115.0%
Analyst target vs. price+99.5%+34.9%
Analyst buy share89%100%
RSI (14)3464
30-day volatility80.2%64.4%
Max drawdown, 1 year-40.1%-60.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VRDN is the largest of the group by market value.
  • ABCL has returned the most over the past year.
  • ABCL is growing revenue fastest.
  • ABCL keeps the most profit per dollar of sales.
  • VRDN has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top